BANK OF AMERICA CORP /DE/
BankPosition in FULC — Fulcrum Therapeutics, Inc.
CIK 70858
CHARLOTTE, NC
Position in FULC
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$970,707
-$1,643,903 QoQ
Shares Held
126,559
-45.3% QoQ
Ownership
0.190%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 168 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FULC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,554,846,017 across 346 Biotechnology names. FULC ranks #210 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in FULC
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $970,707 | 126,559 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $2,614,610 | 231,177 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,354,340 | 147,211 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $316,403 | 45,989 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $161,668 | 56,135 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $431,770 | 91,866 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $356,696 | 99,915 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $433,292 | 69,886 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $582,004 | 61,653 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,265,435 | 187,472 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $617,354 | 139,044 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $436,384 | 132,238 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $120,752 | 42,370 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $419,567 | 57,633 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $241,226 | 29,818 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $507,967 | 103,667 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $350,752 | 14,831 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $494,682 | 27,964 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $210,671 | 7,468 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $107,702 | 10,277 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $58,958 | 5,005 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $198,741 | 16,972 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $29,079 | 3,667 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $298,711 | 16,332 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $185,236 | 15,514 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||